OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2023$0.7956

China Ludao Technology Co Ltd

Specialty ChemicalsVerified

China Ludao Technology operates with a debt-to-equity ratio of 1.56, indicating a capital structure that is moderately leveraged, and a current ratio of 0.71, suggesting potential liquidity constraints. The company's market price of 0.79 CNY and a market cap of 388.5 million CNY reflect a price-to-earnings ratio of 6.91 and a price-to-book ratio of 0.65, both below the industry median for Specialty Chemicals. Profitability metrics show a return on equity of 9.41% and a return on assets of 2.92%, which are below the industry average for Specialty Chemicals. The company's operating margin is 6.84% (76.5 million CNY operating income on 1.12 billion CNY revenue), and net margin is 5.03% (56.3 million CNY net income), both of which are below the median for its industry. The company's revenue is concentrated in four product categories: household and auto care, air fresheners, personal care, and insecticides. It operates primarily in domestic and overseas markets, with no disclosed segment revenue breakdown. The company's reliance on a limited number of product lines and geographic regions may expose it to concentration risk. Outlook data indicates a projected revenue growth of 5.2% for the current fiscal year and 3.8% for the next, driven by expansion in the OBM segment and increased demand for aerosol products in China. However, the company's operating cash flow is negative at -48.5 million CNY, and free cash flow is only 12.5 million CNY, which may limit its ability to fund growth initiatives without external financing. The company faces a medium liquidity risk due to a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no near-term pressure from share issuance. The company's capital expenditures of -59.4 million CNY suggest ongoing investment in production capacity, but the negative operating cash flow may constrain future spending. Recent filings and transcripts indicate the company is focused on expanding its OBM brand presence in China and improving production efficiency. No major regulatory or geopolitical risks are disclosed in the latest filings, though the company's exposure to global supply chains may be affected by trade tensions.

30-day price · 2023+0.04 (+5.3%)
Low$0.67High$0.81Close$0.79As of21 May, 00:00 UTC
Profile
CompanyChina Ludao Technology Co Ltd
Ticker2023.HK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. China Ludao Technology Co Ltd develops, produces, and sells aerosol products for household and auto care, air fresheners, personal care, and insecticides, generating revenue through contract manufacturing for overseas markets and branded sales in China under the Green Island, Ludao, JIERJIA, and EAGLEIN KING brands.

Classification. The company is classified in the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence, aligning with Household Products and 5110103010 activity code.

China Ludao Technology operates with a debt-to-equity ratio of 1.56, indicating a capital structure that is moderately leveraged, and a current ratio of 0.71, suggesting potential liquidity constraints. The company's market price of 0.79 CNY and a market cap of 388.5 million CNY reflect a price-to-earnings ratio of 6.91 and a price-to-book ratio of 0.65, both below the industry median for Specialty Chemicals. Profitability metrics show a return on equity of 9.41% and a return on assets of 2.92%, which are below the industry average for Specialty Chemicals. The company's operating margin is 6.84% (76.5 million CNY operating income on 1.12 billion CNY revenue), and net margin is 5.03% (56.3 million CNY net income), both of which are below the median for its industry. The company's revenue is concentrated in four product categories: household and auto care, air fresheners, personal care, and insecticides. It operates primarily in domestic and overseas markets, with no disclosed segment revenue breakdown. The company's reliance on a limited number of product lines and geographic regions may expose it to concentration risk. Outlook data indicates a projected revenue growth of 5.2% for the current fiscal year and 3.8% for the next, driven by expansion in the OBM segment and increased demand for aerosol products in China. However, the company's operating cash flow is negative at -48.5 million CNY, and free cash flow is only 12.5 million CNY, which may limit its ability to fund growth initiatives without external financing. The company faces a medium liquidity risk due to a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no near-term pressure from share issuance. The company's capital expenditures of -59.4 million CNY suggest ongoing investment in production capacity, but the negative operating cash flow may constrain future spending. Recent filings and transcripts indicate the company is focused on expanding its OBM brand presence in China and improving production efficiency. No major regulatory or geopolitical risks are disclosed in the latest filings, though the company's exposure to global supply chains may be affected by trade tensions.
Key takeaways
  • China Ludao Technology has a price-to-earnings ratio of 6.91 and a price-to-book ratio of 0.65, both below the industry median for Specialty Chemicals.
  • The company's return on equity of 9.41% and return on assets of 2.92% are below the industry average, indicating lower profitability.
  • Revenue is concentrated in four product categories and two geographic markets, exposing the company to concentration risk.
  • The company projects 5.2% revenue growth for the current fiscal year and 3.8% for the next, but negative operating cash flow may limit growth funding.
  • Liquidity risk is medium due to a negative net cash position, and dilution risk is low with no near-term pressure from share issuance.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.12B
Gross profit$151.6M
Operating income$76.5M
Net income$56.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$48.5M
CapEx-$59.4M
Free cash flow$12.5M
Total assets$1.93B
Total liabilities$1.33B
Total equity$597.6M
Cash & equivalents
Long-term debt$931.9M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.12B$76.5M$56.3M$12.5M
FY-1$906.8M$63.9M$51.3M-$39.4M
FY-2$705.8M$58.9M$43.6M-$49.5M
FY-3$534.7M$38.6M$22.3M-$123.2M
FY-4$476.4M$59.7M$35.5M-$78.0M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$1.93B$597.6M
FY-1$1.69B$447.0M
FY-2$1.39B$409.2M
FY-3$1.15B$372.6M
FY-4$933.8M$377.8M
PeriodOCFCapExFCFSBC
FY0-$48.5M-$59.4M$12.5M
FY-1$191.7M-$104.3M-$39.4M
FY-2$30.0M-$109.2M-$49.5M
FY-3$41.9M-$161.8M-$123.2M
FY-4$6.4M-$130.9M-$78.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.79
Market cap$388.5M
Enterprise value$1.32B
P/E6.9
Reported non-GAAP P/E
EV/Revenue1.2
EV/Op income17.3
EV/OCF
P/B0.7
P/Tangible book0.7
Tangible book$597.6M
Net cash-$931.9M
Current ratio0.7
Debt/Equity1.6
ROA2.9%
ROE9.4%
Cash conversion-86.0%
CapEx/Revenue-5.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2023Activity
Op margin6.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin5.0%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin13.6%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-5.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity156.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:38 UTC#1fcf4597
Market quoteclose CNY 0.79 · shares 0.49B diluted
no public URL
2026-05-12 01:38 UTC#77eecaa4
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 01:40 UTCJob: 460e2a38